“Watch and wait” strategy after neoadjuvant chemoradiotherapy in rectal cancer: opportunities and challenges
This article discusses both the opportunities and challenges of the “Wait and Watch” approach to rectal cancer patients.
-
-
Endoanal ultrasonography in establishing the diagnosis of fecal incontinence
The aim of this article is to review the possibilities of using endoanal ultrasound in the evaluation of fecal incontinence.
-
Lack of Complete Pretreatment Staging Is Associated with Omission of Neoadjuvant Therapy for Rectal Cancer: A Statewide Study
Surgeons and other physicians must consistently recognize when a patient has mid-to-low RC and should perform local RC staging for these cases. This includes pelvic MRI or endorectal ultrasound (ERUS), from which the clinical T-stage and N-stage are derived for treatment decision-making.
-
Benign & Malignant Disease and Rectal Cancer Staging
Transrectal ultrasound is useful in early rectal cancer staging as well as in determining benign & malignant disease states. Treatment options can be managed on the same day as the exam.
-
Catalyst XL Compact Ultrasound System
The Catalyst XL Compact Ultrasound System is designed for exam environments tight on space and includes an integrated all-in-one PC.
-
Transrectal Probe 360˚ with Water Pathway 2D/3D
Halo’s Transrectal Ultrasound Probe with 2D & 3D capabilities is ideal for colon & rectal specialists.
-
Transrectal Probe 360˚with Water Pathway 2D
Halo’s Transrectal Ultrasound 2D Probe with water pathway is ideal for colon & rectal specialists.
-
Catalyst XL Conventional Ultrasound System
The Catalyst XL Conventional Ultrasound System is designed for high volume exam environments and includes integrated probe holders and a large workspace.
